0001870913-23-000016.txt : 20231120 0001870913-23-000016.hdr.sgml : 20231120 20231120205810 ACCESSION NUMBER: 0001870913-23-000016 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231114 FILED AS OF DATE: 20231120 DATE AS OF CHANGE: 20231120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shanmugam Muthusamy CENTRAL INDEX KEY: 0001870913 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-31812 FILM NUMBER: 231424255 MAIL ADDRESS: STREET 1: C/O ANI PHARMACEUTICALS, INC. STREET 2: 210 MAIN STREET WEST CITY: BAUDETTE STATE: MN ZIP: 56623 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001023024 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 582301143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 MAIN STREET WEST CITY: BAUDETTE STATE: MN ZIP: 56623 BUSINESS PHONE: 2186343500 MAIL ADDRESS: STREET 1: 210 MAIN STREET WEST CITY: BAUDETTE STATE: MN ZIP: 56623 FORMER COMPANY: FORMER CONFORMED NAME: BIOSANTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19991228 FORMER COMPANY: FORMER CONFORMED NAME: BEN ABRAHAM TECHNOLOGIES INC DATE OF NAME CHANGE: 19991027 4/A 1 wk-form4a_1700531880.xml FORM 4/A X0508 4/A 2023-11-14 2023-11-16 0 0001023024 ANI PHARMACEUTICALS INC ANIP 0001870913 Shanmugam Muthusamy C/O ANI PHARMACEUTICALS, INC. 210 MAIN STREET WEST BAUDETTE MN 56623 1 1 0 0 HEAD OF R&D, COO-NOVITIUM OPS 1 Common Stock 2023-11-14 4 S 0 22905 53.17 D 1009715 I Held by Esjay LLC Common Stock 2023-11-15 4 S 0 7647 53.64 D 1002068 I Held by Esjay LLC Common Stock 2023-11-16 4 S 0 6448 51.66 D 995620 I Held by Esjay LLC The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.95 to $54.07, inclusive. The Reporting Person holds voting and dispositive power over the shares held by Esjay LLC. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $52.96 to $54.24, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.14 to $52.70, inclusive This amendment is being filed to address an administrative error in reporting the number of shares sold in a transaction on November 14, 2023. /s/ Muthusamy Shanmugam, by attorney-in-fact Meredith W. Cook 2023-11-20